Clinical Trials Browser

Phase 3 × Hematologic Neoplasms × CPI-0610 × Clear all

NCT06401356 2025-06-22

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Phase 3 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms